{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:50:52Z","timestamp":1769316652531,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"VA Health Services Research and Development-funded Center to Improve Veteran Involvement in Care at the VA Portland Health Care System","award":["CIN 13-404"],"award-info":[{"award-number":["CIN 13-404"]}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01 AA022886 (Kraemer)"],"award-info":[{"award-number":["R01 AA022886 (Kraemer)"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01 AA020790 (Justice)"],"award-info":[{"award-number":["U01 AA020790 (Justice)"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.drugalcdep.2019.01.038","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T02:01:02Z","timestamp":1552096862000},"page":"70-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Predictors of timely opioid agonist treatment initiation among veterans with and without HIV"],"prefix":"10.1016","volume":"198","author":[{"given":"Jessica J.","family":"Wyse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Manhapra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"Gaither","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsha","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Skanderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Declan T.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Justice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/QAI.0000000000000615","article-title":"HIV care continuum applied to the US Department of Veterans Affairs: HIV virologic outcomes in an integrated health care system","volume":"69","author":"Backus","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13722-017-0083-z","article-title":"Screening, treatment initiation, and referral for substance use disorders","volume":"12","author":"Bernstein","year":"2017","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10461-013-0506-0","article-title":"Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail","volume":"17","author":"Chitsaz","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2014.03.006","article-title":"The impact of buprenorphine\/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients","volume":"139","author":"Edelman","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl 1","key":"10.1016\/j.drugalcdep.2019.01.038_bib0030","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/QAI.0b013e3182097537","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone","volume":"56","author":"Fiellin","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2016.01.013","article-title":"Receipt of pharmacotherapy for opioid use disorder by justice-involved US Veterans Health Administration patients","volume":"160","author":"Finlay","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0040","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.mlr.0000223670.00890.74","article-title":"Development and verification of a \"virtual\" cohort using the National VA Health Information System","volume":"44","author":"Fultz","year":"2006","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0740-5472(02)00303-3","article-title":"Establishing the feasibility of performance measures for alcohol and other drugs","volume":"23","author":"Garnick","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0050","first-page":"265","article-title":"Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Prog. Neuro-Psychopharmacol","volume":"30","author":"Gerra","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/a0022776","article-title":"Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration","volume":"25","author":"Gordon","year":"2011","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11414-008-9142-2","article-title":"Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?","volume":"37","author":"Harris","year":"2010","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0065","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.mlr.0000223741.02074.66","article-title":"Veterans aging cohort study (VACS): overview and description","volume":"44","author":"Justice","year":"2006","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAI.0b013e31826741aa","article-title":"Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care","volume":"61","author":"Korthuis","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/09540121.2013.804900","article-title":"The effect of history of injection drug use and alcoholism on HIV disease progression","volume":"26","author":"Lima","year":"2014","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0085","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0269881112444324","article-title":"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP","volume":"26","author":"Lingford-Hughes","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","article-title":"Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration","volume":"160","author":"Manhapra","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta\u2010analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/JHQ.0000000000000106","article-title":"Evidence for misspecification of a nationally used quality measure for substance use treatment","volume":"40","author":"Mattke","year":"2017","journal-title":"J. Healthc. Qual."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0105","first-page":"633","article-title":"Developing performance measures for alcohol and other drug services in managed care plans","volume":"26","author":"McCorry","year":"2000","journal-title":"Comm. J. Qual. Improv."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2004.06.037","article-title":"Treatment of depression in patients with opiate dependence","volume":"56","author":"Nunes","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00952990.2012.741167","article-title":"Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand?","volume":"39","author":"Oliva","year":"2013","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.15288\/jsad.2017.78.588","article-title":"Association between process based quality indicators and mortality for patients with substance use disorders","volume":"78","author":"Paddock","year":"2017","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1377\/hlthaff.2011.0268","article-title":"The case for measuring quality in mental health and substance abuse care","volume":"30","author":"Pincus","year":"2011","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0140","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","article-title":"The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study","volume":"103","author":"Roux","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0145","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","volume":"49","author":"Roux","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0150","series-title":"Stata Statistical Software","author":"Stata Corp 015","year":"2019"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0155","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1037\/1541-1559.4.3.149","article-title":"Prevalence of substance use disorders among veterans and comparable nonveterans from the National Survey on Drug Use and Health","volume":"4","author":"Wagner","year":"2007","journal-title":"Psychol. Serv."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0165","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1377\/hlthaff.2011.0509","article-title":"Care for veterans with mental and substance use disorders: good performance, but room to improve on many measures","volume":"30","author":"Watkins","year":"2011","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0170","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/QAI.0b013e3182097426","article-title":"The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine\/naloxone and HIV treatment","volume":"56","author":"Weiss","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2019.01.038_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) Health Care System: historical perspective, lessons learned and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Subst. Abus."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619300705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619300705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:56:58Z","timestamp":1759827418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619300705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":35,"alternative-id":["S0376871619300705"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.038","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}